Release Date: 26/08/11 14:05 Summary: Appendix 4E and Full Year Financial Report Price Sensitive: Yes Download Document 1.4MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%